CLINICAL_TRIALS
trial_result
· 2024-04-23
Clinical Trial Update: A Study of SHP655 (rADAMTS13) in Sickle Cell Disease [Phase 1]
Summary
Phase 1 trial update for SHP655 (rADAMTS13) in sickle cell disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Sickle Cell Disease | Phase 1 | Status: COMPLETED | Results posted: 2024-04-23